Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TTAX01 in Non-Healing Venous Leg Ulcers
NCT03818828Phase 2Completed
- Sponsor
- BioTissue
- Start
- Feb 2019
- Primary completion
- Dec 2019
- Modality
- Tissue Cells
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of TTAX01 in venous leg ulcer (VLU), sponsored by BioTissue. Primary endpoint: Complete wound healing at 12 weeks. Started Feb 2019; status: completed.
02
Drugs
TTAX01
03
Conditions
venous leg ulcer (VLU)
Beyond the preview
Go deeper on NCT03818828.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03818828.